$3.35M Philadelphia Medical Malpractice Verdict Against Radiologists For Misread Mammograms

On August 30, 2017, a Philadelphia medical malpractice jury returned its verdict in favor of the plaintiff in the amount of $3.35 million against two radiologist and a hospital for their alleged failure to diagnose the plaintiff’s breast cancer from two mammograms that were performed one year apart.

The 54-year-old plaintiff alleged in her Philadelphia medical malpractice lawsuit that she had mammograms in 2012 and 2013 that showed suspicious calcifications in her breast tissue. The defendant radiologists, who interpreted the mammograms, should have diagnosed her breast cancer at the time of the mammograms, according to the plaintiff’s breast cancer misdiagnosis lawsuit.

The woman had undergone annual mammograms since 2009, when another doctor had identified suspicious calcifications in her breast. A more detailed examination after the 2009 mammogram was interpreted by one of the defendant radiologists as benign. As a result of the 2009 mammogram, the woman was advised to undergo routine mammograms.

The woman’s delayed diagnosis breast cancer medical malpractice lawsuit alleged that her 2012 and 2013 mammograms were read by one of the defendant radiologists as showing no evidence of malignancy. As a result, her recommended medical care was limited to an annual follow-up only.

During the plaintiff’s October 2013 visit to her gynecologist, she discovered a lump in her armpit and her gynecologist found a lump in her breast. As a result, the gynecologist ordered additional medical testing that determined that the woman had stage 3 breast cancer.

The woman filed her Philadelphia misdiagnosis of breast cancer medical malpractice lawsuit in August 2014, alleging that due to the late diagnosis of her breast cancer (misdiagnosis of breast cancer), she had to have painful and invasive surgeries that would have been unnecessary had the defendants not breached the standard of care (i.e., due to the medical negligence of the medical malpractice defendants, the woman’s breast cancer was not diagnosed earlier, which would have resulted in an earlier stage of breast cancer at diagnosis and less painful and invasive medical treatment as a result). The delay in diagnosis of the woman’s breast cancer also means that her chances of suffering a recurrence of breast cancer in the future is increased, which weighs heavily on her emotional well-being on a daily basis.

The defendants have not indicated their intentions with regard to filing post-verdict motions or filing an appeal.

Source

Stage 3 Breast Cancer

According to the National Breast Cancer Foundation, stage 3 cancer means that the breast cancer has extended to beyond the immediate region of the tumor and may have invaded nearby lymph nodes and muscles, but has not spread to distant organs. Although stage 3 is considered to be advanced, there are a growing number of effective treatment options. Stage 3 is further divided into three groups: Stage 3A, Stage 3B, and Stage 3C. The difference is determined by the size of the tumor and whether cancer has spread to the lymph nodes and surrounding tissue.

Source

If you or a family member may have been harmed due to a misread mammogram in Philadelphia or elsewhere in the United States, you should promptly seek the advice of a local medical malpractice lawyer in your U.S. state who may investigate your medical malpractice claim for you and represent you in a medical malpractice case, if appropriate.

Click here to visit our website or call us toll-free in the United States at 800-295-3959 to be connected with medical malpractice lawyers in your state who may assist you.

Turn to us when you don’t know where to turn.

This entry was posted on Thursday, September 21st, 2017 at 5:15 am. Both comments and pings are currently closed.

placeholder

Easy Free Consultation

Fill out the form below for a free consultation or contact us directly at 800.295.3959

Easy Free Consultation

Fill out the form below for a free consultation or contact us directly at 800.295.3959